Structure-guided design of a trivalent nanobody cluster targeting SARS-CoV-2 spike protein
Description
Nanobodies are natural anti-SARS-CoV-2 drug candidates. Engineering multivalent nanobodies is an effective way to improve the functional binding affinity of natural nanobodies by simultaneously targeting multiple sites on viral proteins. However
